ReMinded

03/02/2026

Grateful that ReMinded has been named one of 10 Companies to Watch for 2026 💪🏽 Our priority has been getting the science and regulatory fundamentals right, and it’s encouraging to see that work recognized.

Building locally in New York has raised the bar for how we execute as a team every day. Appreciative of DHNY for recognizing companies willing to take on the hard, often unglamorous work healthcare requires.

09/01/2026

24/09/2025

Presenting season has started🎙️

Last week, we proudly brought home the grand prize 🏆 at the Deal Making Summit Pitch Competition in NYC, securing $10,000 in non-dilutive funding to fuel our mission of improving outcomes in mental healthcare with cortisol monitoring💡

Now, we’re equally thrilled to share that ReMinded has been selected as a Top 25 Quarterfinalist in the .usa 2025 Pitch Competition looking to secure the main prize of $30,000! 🚀

Both moments represent belief in the work we’re doing to make psychiatry smarter and more intentional, powered by physiological stress data.

👉 Learn more about the eosera® competition at eosera.com/pages/pitch

17/08/2025

A few weeks ago, our Co-Founder & CEO, Annika Lundström, took the stage at the United Nations to speak on women- and youth-led innovation and leadership in NYC.

At ReMinded, we believe in showing what it really looks like to step into unfamiliar industries, with courage, resilience, and authenticity. Progress doesn’t come without challenge, and that pushing boundaries is simply the cost of entry to creating real change.

💡 In a world where women remain underrepresented in leadership, we’re proud to be building a female-founded, globally diverse MedTech company, proving every day that results matter more than stereotypes.

Thank you to the Permanent Mission of Finland to the UN, Nuorten Agenda 2030, and Jenni Palukka for making this initiative possible, and for bringing together voices that inspire the next generation of innovators. 🙌

Here’s to more leaps of faith, more women leading, and a healthier future for all. 🫡

17/06/2025

ReMinded has received approval to initiate our Investigational Device Exemption (IDE) study for our saliva-based cortisol detection test! 🎉

This marks a major milestone in our clinical validation journey toward FDA clearance (anticipated in Q4 2025) and brings us one step closer to transforming how mental health conditions are measured and managed.

Our team is deeply committed to advancing accessible, non-invasive solutions, and this IDE approval validates both the strength of our science and the urgency of our mission.

Stay tuned as we enter this clinical phase and continue driving innovation in mental health care. More updates coming soon.

05/03/2025

ReMinded was honored to join the Global Health Innovators Spotlight panel at the Frontiers Summit 2025 by Phase Capital last week in Nashville, Tennessee. 💫

Change is driven by bold actions, and Annika, Adil, and Sanjida are actively pushing the boundaries of what’s possible with saliva-based cortisol sensors this year.🔬

A huge thank you to the Wond’ry at Vanderbilt University and the Nashville community for warmly welcoming our CEO once again.

09/02/2025

Reflecting on nearly a year of progress, ReMinded is grateful for the abundant opportunities we’ve had in the U.S. so far. The support and innovation we’ve experienced, particularly in Nashville, have played a pivotal role in our success. We’re thrilled to head to the Frontiers Summit 2025, where our CEO, Annika Lundström, will be part of the Global Biotech Innovation panel, contributing to discussions that are shaping the future of healthcare.

📅 When: February 27-28, 2025
📍 Where: Noah Liff Opera Center, Nashville, TN
Summit Website + Tickets: https://phasecapital.co/frontiers-summit/



28/01/2025

Check out our latest feature on 🎉 Dive into how we’re making mental health care more measurable with rapid cortisol testing and transforming the way stress is assessed. 🚀Article linked in the comments👇🏼

07/01/2025

Huge congratulations to our talented co-founder Adil Shah for being awarded a spot on the Dean’s List at Aalto University for the 2023-2024 academic year! 🏆

This accomplishment is especially meaningful as Adil continues to lead as CTO at ReMinded, where he’s been driving innovation in design, hardware, and software development. 🚀

Adil’s contributions are making a big impact and we’re so proud of all his achievements this past year! 👏

Here’s to more growth and success in 2025! 🌟

15/09/2024

ReMinded is expanding its reach on the East Coast and will be presenting at the MedInvest Conferences for Biotech & Pharma in NYC on September 18-19, 2024! 🎤

Joined by 125+ top investors, life sciences leaders, and 40+ Presenting Companies, we look forward to connecting with key players and sharing insights on the future of behavioural health while discussing the latest advancements and innovations in the healthcare industry.🩺